Abstract
HEREDITARY spherocytosis (HS) is one of the most common hereditary haemolytic anaemias1. HS red cells from both autosound dominant and recessive variants are spectrin-deficient2,3, which correlates with the severity of the disease3. Some patients with recessive HS have a mutation in the spectrin α-2 domain (S.L.M. et al., unpublished observations), and a few dominant HS patients have an unstable β-spectrin that is easily oxidized4, which damages the protein 4.1 binding site and weakens spectrin-actin interactions5,6. In most patients, however, the cause of spectrin deficiency is unknown. The α- and β-spectrin loci are on chromosomes 1 and 14 respectively7–9. The only other genetic locus for HS is SPH2, on the short arm of chromosome 8 (8p11)10–14. This does not correspond to any of the known loci of genes for red cell membrane proteins including protein 4.1 (Ip36.2-p34)15, the anion exchange protein (AE1, band 3; 17q21-qter)16,17, glycophorin C (2ql4-q21)18, and β-actin (7pter-q22)19. Human erthrocyte ankyrin, which links β-spectrin to the anion exchange protein, has recently been cloned20,21. We now show that the ankyrin gene maps to chromosome 8pll.2, and that one copy is missing from DNA of two unrelated children with severe HS and heterozygous deletions of chromosome 8 (del(8Xpll-p21.1)). Affected red cells are also ankyrin-deficient. The data suggest that defects or deficiency or ankyrin are responsible for HS at the SPH2 locus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lux, S. E. & Becker, P. S. in The Metabolic Basis of Inherited Disease 6th edn (eds Scriver, C.R., Beaudet, A., Sly, W. & Valle, D.) 2367–2408 (McGraw-Hill, New York, 1989).
Agre, P., Casella, J. F., Zinkham, W. H., McMillan, C. & Bennett, V. Nature 314, 380–383 (1985).
Agre, P., Asimos, A., Casella, J. F., & McMillan, C. New Engl. J. Med. 315, 1579–1583 (1986).
Becker, P. S., Morrow, J. S. & Lux, S. E. J. clin. Invest. 80, 557–565 (1987).
Goodman, S. R., Shiffer, K. A., Casoria, L. A. & Eyster, M. E. Blood 60, 772–784 (1982).
Wolfe, L. C., John, K. M., Falcone, J. C., Byrne, A. M. & Lux, S. E. New Engl. J. Med. 307, 1367–1374 (1982).
Huebner, K. et al. Proc. natn. Acad. Sci. U.S.A. 82, 3790–3793 (1985).
Prchal, J. T. et al. Proc. natn. Acad. Sci. U.S.A. 84, 7468–7472 (1987).
Winkelmann, J. C., et al. Blood 72, 328–334 (1988).
Kimberling, W. J., Fulbeck, T., Dixon, L. & Lubs, H. A. Am. J. hum. Genet. 27, 586–594 (1975).
Kimberling, W. J., Taylor, R. A., Chapman, R. G. & Lubs, H. A. Blood 52, 859–867 (1978).
Bass, E. B., Smith, S. W. Jr, Stevenson, R. E. & Rosse, W. F. Ann. intern. Med. 99, 192–193 (1983).
Chilcote, R. R. et al. Blood 69, 156–159 (1987).
Kitatani, M., Chiyo, H., Ozaki, M., Shike, S. & Miwa, S. Hum. Genet. 78, 94–95 (1988).
Conboy, J., Mohandas, N., Tchernia, G. & Kan, Y. W. New Engl. J. Med. 15, 680–685 (1986).
Showe, L. C., Ballantine, M. & Huebner, K. Genomics 1, 71–76 (1987).
Lux, S. E., John, K. M., Kopito, R. R. & Lodish, H. F. Proc. natn. Acad. Sci. U.S.A. 86, 9089–9093 (1989).
Mattei, M. G., Colin, Y., Le Van Kim, C., Mattei, J. F. & Cartron, J. P. Hum. Genet. 74, 420–422 (1986).
Ng, S. Y. et al. Molec. cell. Biol. 5, 2720–2732 (1985).
Lux, S. E., John, K. & Bennett, V. Nature 344, 36–42 (1990).
Lambert, S. et al. Proc. natn. Acad. Sci. U.S.A. 87, 1730–1734 (1990).
Harris, P. et al. Hum. Genet. 77, 95–103 (1987).
Magenis, R. E., Reiss, J., Bigley, R., Chamberlain, J. & Lovrien, E. Cytogenet. Cell Genet. 22, 446–448 (1978).
Searle, A. G. et al. Genomics 1, 3–18 (1987).
White, R. A., Birkenmeier, C. S., Lux, S. E. & Barker, J. E. Proc. natn. Acad. Sci. U.S.A. 87, 3117–3121 (1990).
Kopito, R. R., Andersson, M. & Lodish, H. F. J. biol. Chem. 262, 8035–8040 (1987).
Lichter, P. et al. Science 247, 64–69 (1990).
Bennett, V. & Stenbuck, P. J. J. biol. Chem. 254, 2533–2541 (1979).
Korsgren, C. & Cohen, C. N. J. biol. Chem. 263, 10212–10218 (1988).
Cooper, R. A. & Jandl, J. H. J. clin. Invest. 48, 736–744 (1969).
Coetzer, T. L. et al. New Engl. J. Med. 318, 230–234 (1988).
Feinberg, A. P. & Vogelstein, B. Analyt. Biochem. 137, 266 (1984).
Sullivan, D. E. et al. Biotechniques 5, 672–678 (1987).
Lawn, R. M., Fritsch, E. F., Parker, R. C., Blake, G. & Maniatis, T. Cell 15, 1157–1174 (1978).
Fairbanks, G., Steck, T. L. & Wallach, D. F. H. Biochemistry 10, 2606–2617 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lux, S., Tse, W., Menninger, J. et al. Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature 345, 736–739 (1990). https://doi.org/10.1038/345736a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/345736a0
This article is cited by
-
A hierarchy of ankyrin-spectrin complexes clusters sodium channels at nodes of Ranvier
Nature Neuroscience (2014)
-
Ankyrin-B structurally defines terminal microdomains of peripheral somatosensory axons
Brain Structure and Function (2013)
-
Ankrd7, a Novel Gene Specifically Expressed in Sertoli Cells and Its Potential Roles in Sertoli Cell Maturation
Molecules and Cells (2009)
-
Ankyrin–1 mutations are a major cause of dominant and recessive hereditary spherocytosis
Nature Genetics (1996)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
